Roivant Sciences Ltd.
USD34.96
+0.91 (+2.67%)
CEO
Matthew Gline
IPO Date
2020-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$34.20
Prev. Close
$34.05
Day Low
$34.02
Day High
$35.24
52W Low
$10.90
52W High
$37.00
Market Cap
$25.15B
Volume
4.61M
| 10,000 |
| $8.80 |
| 2 Jul 2026 | Fitzgerald Meghan | director | S-Sale | Disposed | 10,000 | $34.90 |
| 2 Jul 2026 | Fitzgerald Meghan | director | M-Exempt | Disposed | 10,000 | $8.80 |
| 2 Jul 2026 | Torti Frank | President and Vant Chair | F-InKind | Disposed | 40,310 | $35.39 |
| 2 Jul 2026 | Sukhatme Mayukh | director, officer: President & CIO | F-InKind | Disposed | 46,878 | $35.39 |
| 1 Jul 2026 | Epperly Melissa B, | director | M-Exempt | Acquired | 17,750 | $4.46 |
| 1 Jul 2026 | Epperly Melissa B, | director | S-Sale | Disposed | 15,002 | $34.32 |
| 1 Jul 2026 | Epperly Melissa B, | director | S-Sale | Disposed | 2,748 | $34.71 |
| 1 Jul 2026 | Epperly Melissa B, | director | M-Exempt | Disposed | 17,750 | $4.46 |